ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.
News | Radiology Business
Siemens Healthineers Set to Acquire Varian in $16.4B Deal

August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly ...

Time August 03, 2020
arrow
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO
ASTRO to Host Virtual Annual Meeting in October

July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting ...

Time July 09, 2020
arrow
 Accuray Incorporated announced the company has launched the CyberKnife S7 System, an innovative device combining speed, advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments — in as little as 15 minutes.
News | Stereotactic Body Radiation Therapy (SBRT)
Accuray Launches New CyberKnife S7 System

June 26, 2020 — Accuray Incorporated announced the company has launched the CyberKnife S7 System, an innovative device ...

Time June 26, 2020
arrow
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration
News | Coronavirus (COVID-19)
FDA Keeps on Track With Medical Product Application Goals

June 23, 2020 — On June 23, 2020, Stephen M. Hahn, M.D., Commissioner of Food and Drugs, released a statement regarding ...

Time June 23, 2020
arrow
Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information
News | Clinical Decision Support
Philips and MD Anderson Collaborate to Provide Oncologists with Evidence-based Therapy, Clinical Trial Guidance

June 16, 2020 — Philips and The University of Texas MD Anderson Cancer Center announced a collaboration to provide ...

Time June 16, 2020
arrow
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer.
News | Radiation Therapy
ASTRO Issues First Clinical Guideline on Radiation Therapy for Cervical Cancer

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration, discussed The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned, on June 1
News | Coronavirus (COVID-19)
Remarks by FDA Commissioner Stephen Hahn, M.D. on the COVID-19 Pandemic

June 5, 2020 — The following speech was delivered by Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and ...

Time June 05, 2020
arrow
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).
News | Coronavirus (COVID-19)
ASTRO Survey Finds Fewer Patient Visits Despite Enhanced COVID-19 Safety Measures

May 21, 2020 — Despite facing challenges such as limited access to personal protective equipment (PPE) following the ...

Time May 21, 2020
arrow
#coronavirus #covid19 #pandemic #ASTRO20
News | ASTRO
ASTRO's Annual Meeting Transitions to Digital Format

May 4, 2020 — Although the 2020 ASTRO Annual Meeting is still months away, the American Society for Radiation Oncology ...

Time May 04, 2020
arrow
360 Photos | 360 View Photos
360 Degree View of a 3-D Printed Bolus for Radiation Therapy

The company .decimal at ASTRO showed a 3-D printing technology where radiation therapy (RT) bolus shields can be printed ...

Time April 30, 2020
arrow
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.
Feature | Treatment Planning | Dave Fornell, Editor
Artificial Intelligence Greatly Speeds Radiation Therapy Treatment Planning

The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new ...

Time April 03, 2020
arrow
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer
Managing Prostate Cancer Patients During the COVID-19 Pandemic

March 30, 2020 — In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is ...

Time March 30, 2020
arrow
Novel scanners may open door for prognostic assessment in patients receiving cochlear implants
News | PET-CT
High-resolution PET/CT Assesses Brain Stem Function in Patients with Hearing Impairment

March 26, 2020 — Novel, fully digital, high-resolution positron emission tomography/computed tomography (PET/CT) imaging ...

Time March 26, 2020
arrow
Reflexion eceived marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion X1 machine
News | Stereotactic Body Radiation Therapy (SBRT)
FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

March 13, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 13, 2020
arrow
“Cyclotrons used in Nuclear Medicine Report & Directory, Edition 2020” that describes close to 1,500 medical cyclotrons worldwide
News | Nuclear Imaging
MEDraysintell Releases Unique Cyclotron Directory

March 10, 2020 — MEDraysintell released its new and unique report “Cyclotrons used in Nuclear Medicine Report & ...

Time March 10, 2020
arrow
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT)
First Accuray CyberKnife M6 System Installed in Missouri

February 27, 2020 — Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment ...

Time February 27, 2020
arrow
Nuclear imaging equipment growth in 2020
News | Nuclear Imaging
APAC Nuclear Imaging Market Projected to Grow at CAGR of 8.9%

February 14, 2020 — The nuclear imaging equipment market in the Asia-Pacific (APAC) region is expected to grow at a ...

Time February 14, 2020
arrow
The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from the U.S. Department of Veterans Affairs (VA) to develop quality indicators (QI) for radiation treatments provided to veterans with head and neck, breast and gastrointestinal cancers
News | Radiation Therapy
ASTRO Awarded Contract from VA to Develop Measures on Quality of Radiation Therapy Services

February 13, 2020 — The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from ...

Time February 13, 2020
arrow
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT)
Varian Receives FDA 510(k) Clearance for Ethos Therapy

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
The radiation therapy market is projected to grow in through 2026
News | Proton Therapy
Global Radiation Therapy Market to Reach $8.6B by 2026

February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...

Time February 10, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now